-+ 0.00%
-+ 0.00%
-+ 0.00%

Traws Pharma Enters Stock Purchase Agreement With Roth Principal Investments On Oct 23, 2026; May Sell Up To $50M In Common Stock To Roth Principal Investments

Benzinga·10/23/2026 21:23:13
语音播报

-SEC Filing